Document Classification

Section Type: RESULTS

Text: There was no difference in hospital length of stay (3. 75 + / - 2. 19 vs. 3. 86 + / - 3. 06 days for zileuton vs. placebo, p = 0. 39) or treatment failure (23 % vs. 27 % for zileuton vs. placebo, p = 0. 63) despite a decline in urinary LTE (4) levels in the zileuton-treated group as compared to placebo at 24 hours (change in natural log-transformed ng/mg creatinine -1. 38 + / - 1. 19 vs. 0. 14 + / - 1. 51, p < 0. 0001) and 72 hours (-1. 32 + / - 2. 08 vs. 0. 26 + / - 1. 93, p < 0. 006).